MedVellum
Clinical Atlas OS
ANZCA Examinations atlas
ANZCA Final
Regional Anaesthesia
Perioperative Medicine
High Evidence
AI-generated

Spinal Anaesthesia

Spinal anaesthesia involves injection of local anaesthetic into the subarachnoid space producing rapid, dense sensory and motor block with predictable dermatomal distribution. Mechanism: Local anaesthetic acts on...

AI
Content
Generated education
2 Feb 2026
Updated
1 min
Read time
Answer card

What matters first

Clinical frame

Spinal anaesthesia involves injection of local anaesthetic into the subarachnoid space producing rapid, dense sensory and motor block with predictable dermatomal distribution. Mechanism: Local anaesthetic acts on...

Do not miss

Total spinal with cardiovascular collapse and respiratory failure

Updated

2 Feb 2026

AI disclosure

Generated educational material; verify before clinical use.

Evidence

96 cited sources

Content status
AI-generated educational content
Reviewer claim
No individual clinician credential claimed
References
96 cited sources
Quality score
55 (gold)

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • Total spinal with cardiovascular collapse and respiratory failure
  • High spinal causing severe hypotension and bradycardia
  • Post-dural puncture headache (PDPH) preventing ambulation
  • Cauda equina syndrome from neurotoxicity

Exam focus

Current exam surfaces linked to this topic.

  • ANZCA Final Written
  • ANZCA Final Clinical Viva
  • ANZCA Final Medical Viva

Content status and exam context

This page is AI-generated educational content. It may contain errors or omissions and is not a substitute for current guidelines, local protocols, senior clinical judgement, or professional medical advice.

MedVellum does not claim an individual clinician reviewer, board certification, or professional credential for this page unless a future version names a real, verifiable reviewer.

ANZCA Final Written
ANZCA Final Clinical Viva
ANZCA Final Medical Viva
Topic guide

Clinical explanation and evidence

Quick Answer

Spinal anaesthesia involves injection of local anaesthetic into the subarachnoid space producing rapid, dense sensory and motor block with predictable dermatomal distribution. Mechanism: Local anaesthetic acts on nerve roots and spinal cord blocking sodium channels, with small unmyelinated C fibers (pain) blocked before large myelinated A fibers (motor). Technique: Midline or paramedian approach at L3-L4 or L4-L5 interspace (below conus medullaris which ends at L1-L2 in adults), using 25-27G pencil-point needles (Whitacre, Sprotte) to reduce PDPH risk. Standard caesarean section dose: Hyperbaric bupivacaine 0.5% 2.2-2.5 mL (11-12.5 mg) with fentanyl 10-20 μg and morphine 100-200 μg for postoperative analgesia. Onset: 2-5 minutes (faster than epidural), duration 90-180 minutes depending on drug/dose. Hypotension occurs in 15-30% due to sympathetic blockade (T4-L1), managed with left uterine displacement, fluid preload 500-1000 mL, phenylephrine 50-100 μg IV bolus or infusion 50-100 μg/min. PDPH incidence 1-2% with modern needles, treated with epidural blood patch (15-20 mL autologous blood) if severe/persistent. Contraindications: Patient refusal, coagulopathy (platelets <80 × 10⁹/L), infection at site, severe hypovolaemia, increased ICP. Indigenous patients have higher rates of obesity and OSA increasing technical difficulty and PDPH risk, requiring careful positioning and culturally sensitive consent processes. [1-10]